End-of-day quote
Shanghai S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
20.54
CNY
|
-1.20%
|
|
+9.26%
|
-6.89%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,030
|
14,640
|
18,410
|
19,474
|
22,154
|
20,626
|
-
|
-
|
Enterprise Value (EV)
1 |
8,030
|
14,640
|
18,410
|
19,474
|
22,154
|
18,582
|
18,255
|
20,626
|
P/E ratio
|
17.3
x
|
26
x
|
26.6
x
|
27.7
x
|
26.6
x
|
20.2
x
|
16.7
x
|
13.6
x
|
Yield
|
3.02%
|
-
|
1.61%
|
1.55%
|
1.5%
|
1.86%
|
2.12%
|
1.61%
|
Capitalization / Revenue
|
2.92
x
|
4.28
x
|
4.8
x
|
5.92
x
|
5.53
x
|
4.31
x
|
3.63
x
|
3.09
x
|
EV / Revenue
|
2.92
x
|
4.28
x
|
4.8
x
|
5.92
x
|
5.53
x
|
3.88
x
|
3.21
x
|
3.09
x
|
EV / EBITDA
|
11
x
|
15.8
x
|
16.4
x
|
-
|
16.9
x
|
12.5
x
|
10.3
x
|
10.5
x
|
EV / FCF
|
-
|
-
|
33
x
|
-
|
-
|
37
x
|
24.8
x
|
-
|
FCF Yield
|
-
|
-
|
3.03%
|
-
|
-
|
2.7%
|
4.03%
|
-
|
Price to Book
|
1.71
x
|
2.9
x
|
3.36
x
|
3.28
x
|
3.39
x
|
2.82
x
|
2.52
x
|
2.12
x
|
Nbr of stocks (in thousands)
|
9,69,817
|
9,88,526
|
9,89,235
|
10,04,848
|
10,04,253
|
10,04,181
|
-
|
-
|
Reference price
2 |
8.280
|
14.81
|
18.61
|
19.38
|
22.06
|
20.54
|
20.54
|
20.54
|
Announcement Date
|
07/01/20
|
09/01/21
|
14/01/22
|
10/01/23
|
17/01/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,755
|
3,418
|
3,835
|
3,291
|
4,007
|
4,784
|
5,681
|
6,678
|
EBITDA
1 |
728.6
|
925.3
|
1,121
|
-
|
1,312
|
1,487
|
1,772
|
1,972
|
EBIT
1 |
549.3
|
673.5
|
840.2
|
828
|
972.4
|
1,212
|
1,448
|
1,803
|
Operating Margin
|
19.94%
|
19.7%
|
21.91%
|
25.16%
|
24.27%
|
25.33%
|
25.49%
|
27%
|
Earnings before Tax (EBT)
1 |
550.7
|
671.5
|
843
|
823.7
|
971.8
|
1,217
|
1,453
|
1,802
|
Net income
1 |
466.9
|
558.4
|
691.7
|
689.1
|
825.2
|
1,022
|
1,232
|
1,516
|
Net margin
|
16.95%
|
16.34%
|
18.04%
|
20.94%
|
20.6%
|
21.36%
|
21.69%
|
22.7%
|
EPS
2 |
0.4800
|
0.5700
|
0.7000
|
0.7000
|
0.8300
|
1.017
|
1.229
|
1.510
|
Free Cash Flow
1 |
-
|
-
|
557.1
|
-
|
-
|
502
|
736
|
-
|
FCF margin
|
-
|
-
|
14.53%
|
-
|
-
|
10.49%
|
12.96%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
49.72%
|
-
|
-
|
33.77%
|
41.54%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
80.54%
|
-
|
-
|
49.12%
|
59.74%
|
-
|
Dividend per Share
2 |
0.2500
|
-
|
0.3000
|
0.3000
|
0.3300
|
0.3817
|
0.4353
|
0.3300
|
Announcement Date
|
07/01/20
|
09/01/21
|
14/01/22
|
10/01/23
|
17/01/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
2,044
|
2,371
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
557
|
-
|
-
|
502
|
736
|
-
|
ROE (net income / shareholders' equity)
|
10.3%
|
11.6%
|
13.6%
|
12.4%
|
13.6%
|
14.4%
|
15.6%
|
15.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
10.6%
|
11.5%
|
11.6%
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
9,611
|
10,682
|
13,069
|
Book Value Per Share
2 |
4.840
|
5.100
|
5.540
|
5.920
|
6.510
|
7.280
|
8.140
|
9.680
|
Cash Flow per Share
2 |
0.6700
|
0.7200
|
0.7200
|
-
|
0.8600
|
1.300
|
1.510
|
1.730
|
Capex
1 |
436
|
338
|
152
|
-
|
497
|
692
|
718
|
315
|
Capex / Sales
|
15.81%
|
9.88%
|
3.96%
|
-
|
12.41%
|
14.46%
|
12.64%
|
4.72%
|
Announcement Date
|
07/01/20
|
09/01/21
|
14/01/22
|
10/01/23
|
17/01/24
|
-
|
-
|
-
|
Last Close Price
20.54
CNY Average target price
23.35
CNY Spread / Average Target +13.68% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.89% | 2.85B | | 0.00% | 7.03B | | -11.41% | 2.91B | | -27.64% | 1.83B | | -2.47% | 1.16B | | -6.63% | 1.07B | | -10.95% | 831M | | +0.62% | 761M | | -9.74% | 736M | | -19.31% | 719M |
Testing Laboratories
|